中新经纬1月3日电 (王玉玲)近日,AH股上市公司上海医药与H股上市公司和黄医药(中国)有限公司(下称和黄医药)均发布公告称达成收购要约。和黄医药将出售与上海医药合资公司45%的股权。2001年,上海医药与和黄医药以50:50比例成立合资公司上海和黄药业有限公司(下称上海和黄),主要负责在中国生产、销售及分销其自有品牌处方药物,主要产品为心血管疾病的中成药。根据上海医药公告,上海和黄医药2023...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.